Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia
This study is not yet open for participant recruitment.
Verified June 2012 by Dainippon Sumitomo Pharma
Sponsor:
Dainippon Sumitomo Pharma
Information provided by (Responsible Party):
Dainippon Sumitomo Pharma
ClinicalTrials.gov Identifier:
NCT01614912
First received: June 6, 2012
Last updated: June 21, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is not yet open for participant recruitment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | February 2016 (Final data collection date for primary outcome measure) |